BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
37 results:

  • 1. Integrated In-Silico and In Vitro analysis to Decipher the contribution of bisphenol-A in cervical cancer.
    Khan NG; Adiga D; Rai PS; Kabekkodu SP
    Toxicology; 2024 May; 504():153791. PubMed ID: 38555994
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutational landscape of head and neck cancer and cervical cancer in Chinese and Western population.
    Li Q; Zhu G; Zhang L; Zeng B; Cai T; Wu J; Wei B; Xie Z; He L; Tang W; Lin X; Lu H; Wu F; Huang J; Hu H; Liu N; Fan S
    Head Neck; 2024 Mar; 46(3):528-540. PubMed ID: 38111234
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Oncogenic driver fgfr3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability.
    Wang CG; Peiris MN; Meyer AN; Nelson KN; Donoghue DJ
    Oncotarget; 2023 Feb; 14():133-145. PubMed ID: 36780330
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Human papillomavirus integration perspective in small cell cervical carcinoma.
    Wang X; Jia W; Wang M; Liu J; Zhou X; Liang Z; Zhang Q; Long S; Quzhen S; Li X; Tian Q; Li X; Sun H; Zhao C; Meng S; Ning R; Xi L; Wang L; Zhou S; Zhang J; Wu L; Chen Y; Liu A; Ma Y; Zhao X; Cheng X; Zhang Q; Han X; Pan H; Zhang Y; Cao L; Wang Y; Ling S; Cao L; Xing H; Xu C; Sui L; Wang S; Zhou J; Kong B; Xie X; Chen G; Li S; Ma D; Li S
    Nat Commun; 2022 Oct; 13(1):5968. PubMed ID: 36216793
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
    Stubbins RJ; Korotev S; Godley LA
    Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic Correlates of Unfavorable Outcome in Locally Advanced cervical cancer Treated with Neoadjuvant Chemoradiation.
    Wei Y; Wei C; Chen L; Liu N; Ou Q; Yin JC; Pang J; Fang Z; Wu X; Wang X; Mu D; Shao Y; Yu J; Yuan S
    Cancer Res Treat; 2022 Oct; 54(4):1209-1218. PubMed ID: 35038823
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. cervical Precancers Originate From Infected Proliferating Reserve Cells: A Comparative Histologic and Genetic Study of Thin and Thick High-grade Squamous Intraepithelial Lesions.
    Regauer S; Reich O; Kashofer K
    Am J Surg Pathol; 2022 Apr; 46(4):519-527. PubMed ID: 34619706
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
    Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
    Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W.
    Chae YK; Hong F; Vaklavas C; Cheng HH; Hammerman P; Mitchell EP; Zwiebel JA; Ivy SP; Gray RJ; Li S; McShane LM; Rubinstein LV; Patton D; Williams PM; Hamilton SR; Mansfield A; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
    J Clin Oncol; 2020 Jul; 38(21):2407-2417. PubMed ID: 32463741
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. FGFR Signaling as a Candidate Therapeutic Target for cancers Resistant to Carbon Ion Radiotherapy.
    Darwis NDM; Nachankar A; Sasaki Y; Matsui T; Noda SE; Murata K; Tamaki T; Ando K; Okonogi N; Shiba S; Irie D; Kaminuma T; Kumazawa T; Anakura M; Yamashita S; Hirakawa T; Kakoti S; Hirota Y; Tokino T; Iwase A; Ohno T; Shibata A; Oike T; Nakano T
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540114
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.
    Liu GC; Zhou YF; Su XC; Zhang J
    BMC Cancer; 2019 Jan; 19(1):24. PubMed ID: 30616520
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study.
    Deeken-Draisey A; Yang GY; Gao J; Alexiev BA
    Hum Pathol; 2018 Dec; 82():140-148. PubMed ID: 30075157
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.
    Choi CH; Chung JY; Kim JH; Kim BG; Hewitt SM
    J Transl Med; 2016 May; 14(1):124. PubMed ID: 27154171
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Oncogenic Gene Fusion fgfr3-TACC3 Is Regulated by Tyrosine Phosphorylation.
    Nelson KN; Meyer AN; Siari A; Campos AR; Motamedchaboki K; Donoghue DJ
    Mol Cancer Res; 2016 May; 14(5):458-69. PubMed ID: 26869289
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Treatment costs of malignant cervical cancer in Poland in 2011-2012--the case of Silesian Voivodeship].
    Holecki T; Sobczyk K; Nawrocki S; Woźniak-Holecka J; Skrzypek M; Bocionek A
    Ginekol Pol; 2015 Nov; 86(11):849-55. PubMed ID: 26817317
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomic landscape of human papillomavirus-associated cancers.
    Rusan M; Li YY; Hammerman PS
    Clin Cancer Res; 2015 May; 21(9):2009-19. PubMed ID: 25779941
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers.
    Xiang L; Li J; Jiang W; Shen X; Yang W; Wu X; Yang H
    Oncotarget; 2015 Mar; 6(7):4968-75. PubMed ID: 25669975
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Incidental finding of abnormal cervical pathology in hysterectomy specimens after normal preoperative Papanicolaou smears in Thammasat University Hospital.
    Chundarat PA; Suwannarurk K; Bhamarapravatana K; Pattaraarchachai J; Thaweekul Y; Mairaing K; Poomtavorn Y
    Asian Pac J Cancer Prev; 2014; 15(14):5811-4. PubMed ID: 25081705
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers.
    Spaans VM; Trietsch MD; Crobach S; Stelloo E; Kremer D; Osse EM; Haar NT; van Eijk R; Muller S; van Wezel T; Trimbos JB; Bosse T; Smit VT; Fleuren GJ
    PLoS One; 2014; 9(3):e93451. PubMed ID: 24671188
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Muscarinic cholinergic signaling in cervical cancer cells affects cell motility via ERK1/2 signaling.
    Parnell EA; Calleja-Macias IE; Kalantari M; Grando SA; Bernard HU
    Life Sci; 2012 Nov; 91(21-22):1093-8. PubMed ID: 22406505
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.